Low oxytocin and melatonin levels and their possible role in the diagnosis and prognosis in Iraqi autistic children | Saudi Medical Journal

References

↵
1. Brentani H,
2. Paula CS,
3. Bordini D,
4. Rolim D,
5. Sato F,
6. Portolese J,
7. et al.
(2013) Autism spectrum disorders: an overview on diagnosis and treatment. Rev Bras Psiquiatr 35(Suppl 1):S62–S72.
OpenUrl Google Scholar
↵
1. Rogers SJ
(2009) What are infant siblings teaching us about autism in infancy? Autism Res 2:125–137.
OpenUrl CrossRef PubMed Web of Science Google Scholar
↵
1. Ruggeri B,
2. Sarkans U,
3. Schumann G,
4. Persico AM
(2014) Biomarkers in autism spectrum disorder: the old and the new. Psychopharmacology (Berl) 231:1201–1216.
OpenUrl Google Scholar
↵
1. Husarova V,
2. Lakatosova S,
3. Pivovarciova A,
4. Bakos J,
5. Durdiakova J,
6. Kubranska A,
7. et al.
(2013) Brief report: Plasma oxytocin is lower in children with Asperger syndrome and associated with autistic trait attention to detail. Open Journal of Psychiatry 3:399–402.
OpenUrl Google Scholar
↵
1. Carson DS,
2. Garner JP,
3. Hyde SA,
4. Libove RA,
5. Berquist SW,
6. Hornbeak KB,
7. et al.
(2015) Arginine Vasopressin Is a Blood-Based Biomarker of Social Functioning in Children with Autism. PLoS One 10:e0132224.
OpenUrl Google Scholar
↵
1. de Faria Poloni J,
2. Feltes BC,
3. Bonatto D
(2011) Melatonin as a central molecule connecting neural development and calcium signaling. Funct Integr Genomics 11:383–388.
OpenUrl PubMed Google Scholar
↵
1. Carrillo-Vico A,
2. Lardone PJ,
3. Alvarez-Sánchez N,
4. Rodríguez-Rodríguez A,
5. Guerrero JM
(2013) Melatonin: buffering the immune system. Int J Mol Sci 14:8638–8683.
OpenUrl CrossRef PubMed Google Scholar
↵
1. Tordjman S,
2. Anderson GM,
3. Bellissant E,
4. Botbol M,
5. Charbuy H,
6. Camus F,
7. et al.
(2012) Day and nighttime excretion of 6-sulphatoxymelatonin in adolescents and young adults with autistic disorder. Psychoneuroendocrinology 37:1990–1997.
OpenUrl Google Scholar
↵
1. Hammock E,
2. Veenstra-VanderWeele J,
3. Yan Z,
4. Kerr TM,
5. Morris M,
6. Anderson GM,
7. et al.
(2012) Examining autism spectrum disorders by biomarkers: example from the oxytocin and serotonin systems. J Am Acad Child Adolesc Psychiatry 51:712–721.
OpenUrl CrossRef PubMed Google Scholar
↵
1. American Psychiatric Association
(2013) Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric Publishing, Washington (DC)), 5th ed.
Google Scholar
↵
1. Norman G
(2010) Likert scales, levels of measurement and the “laws” of statistics. Adv Health Sci Educ Theory Pract 15:625–632.
OpenUrl CrossRef PubMed Google Scholar
↵
1. Hajian-Tilaki K
(2013) Receiver Operating Characteristic (ROC) Curve Analysis for Medical Diagnostic Test Evaluation. Caspian J Intern Med 4:627–635.
OpenUrl PubMed Google Scholar
↵
1. Hye A,
2. Lynham S,
3. Thambisetty M,
4. Causevic M,
5. Campbell J,
6. Byers HL,
7. et al.
(2006) Proteome-based plasma biomarkers for Alzheimer’s disease. Brain 129:3042–3050.
OpenUrl CrossRef PubMed Web of Science Google Scholar
↵
1. Alabdali A,
2. Al-Ayadhi L,
3. El-Ansary A
(2014) Association of social and cognitive impairment and biomarkers in autism spectrum disorders. J Neuroinflammation 11:4.
OpenUrl Google Scholar
↵
1. Slattery DA,
2. Neumann ID
(2010) Oxytocin and Major Depressive Disorder: Experimental and Clinical Evidence for Links to Aetiology and Possible Treatment. Pharmaceuticals (Basel) 3:702–724.
OpenUrl Google Scholar
↵
1. Matsuzaki M,
2. Matsushita H,
3. Tomizawa K,
4. Matsui H
(2012) Oxytocin: a therapeutic target for mental disorders. J Physiol Sci 62:441–444.
OpenUrl CrossRef PubMed Google Scholar
↵
1. Cao Y,
2. Wu R,
3. Tai F,
4. Zhang X,
5. Yu P,
6. An X,
7. et al.
(2014) Neonatal paternal deprivation impairs social recognition and alters levels of oxytocin and estrogen receptor a mRNA expression in the MeA and NAcc, and serum oxytocin in mandarin voles. Horm Behav 65:57–65.
OpenUrl Google Scholar
↵
1. Lukas M,
2. Neumann ID
(2013) Oxytocin and vasopressin in rodent behaviors related to social dysfunctions in autism spectrum disorders. Behav Brain Res 251:85–94.
OpenUrl CrossRef PubMed Google Scholar
↵
1. Cochran DM,
2. Fallon D,
3. Hill M,
4. Frazier JA
(2013) The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings. Harv Rev Psychiatry 21:219–247.
OpenUrl CrossRef PubMed Web of Science Google Scholar
↵
1. El-Masry N,
2. Soliman A,
3. Abdel Moety H
(2010) Alterations of prolyl endopeptidase, oxytocin and vasopressin activity in the plasma of autistic children. Current Psychiatry 17:31–37.
OpenUrl Google Scholar
↵
1. Quattrocki E,
2. Friston K
(2014) Autism, oxytocin and interoception. Neurosci Biobehav Rev 47:410–430.
OpenUrl CrossRef PubMed Google Scholar
↵
1. Hovey D,
2. Zettergren A,
3. Jonsson L,
4. Melke J,
5. Anckarsäter H,
6. Lichtenstein P,
7. et al.
(2014) Associations between oxytocin-related genes and autistic-like traits. Soc Neurosci 9:378–386.
OpenUrl CrossRef PubMed Google Scholar
↵
1. Talarowska M,
2. Szemraj J,
3. Zajączkowska M,
4. Gałecki P
(2014) ASMT gene expression correlates with cognitive impairment in patients with recurrent depressive disorder. Med Sci Monit 20:905–912.
OpenUrl Google Scholar
↵
1. Kripke DF,
2. Nievergelt CM,
3. Tranah GJ,
4. Murray SS,
5. McCarthy MJ,
6. Rex KM,
7. et al.
(2011) Polymorphisms in melatonin synthesis pathways: possible influences on depression. J Circadian Rhythms 9:8.
OpenUrl CrossRef PubMed Google Scholar
↵
1. Marazziti D,
2. Baroni S,
3. Giannaccini G,
4. Betti L,
5. Massimetti G,
6. Carmassi C,
7. et al.
(2012) A link between oxytocin and serotonin in humans: Supporting evidence from peripheral markers. Eur Neuropsychopharmacol 22:578–583.
OpenUrl CrossRef PubMed Google Scholar
↵
1. Roszczyk M,
2. Juszczak M
(2014) Forskolin-stimulated vasopressin and oxytocin release from the rat hypothalamo-neurohypophysial system in vitro is inhibited by melatonin. Endokrynol Pol 65:125–131.
OpenUrl Google Scholar